| 发明名称 | Method for treating uterine fibroids | ||
| 摘要 | The invention relates to a method for treating uterine fibroids, which method comprises administering to a patient in need thereof, an effective amount of 17α-acetoxy-11β-[4-N,N-dimethylamino-phenyl)-19-norpregna-4,9-diene-3,20-dione (ulipristal) or any metabolite thereof. More particularly, the method is useful for reducing or stopping bleeding in a patient afflicted with uterine fibroids, and/or for reducing the size of uterine fibroids. | ||
| 申请公布号 | US9180133(B2) | 申请公布日期 | 2015.11.10 |
| 申请号 | US201414200100 | 申请日期 | 2014.03.07 |
| 申请人 | LABORATOIRE HRA-PHARMA;THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 发明人 | Nieman Lynnette;Ulmann Andre;Blithe Diana;Gainer Erin |
| 分类号 | A61K31/56;A61K31/57 | 主分类号 | A61K31/56 |
| 代理机构 | Ascenda Law Group PC | 代理人 | Ascenda Law Group PC |
| 主权项 | 1. A method for treating a symptom of uterine fibroids in a patient, wherein the symptom is selected from the group consisting of uterine bleeding, anemia, pelvic pressure, and pelvic pain, the method comprising the step of administering to the patient a daily oral dosage of about 5 mg to 20 mg of 17α-acetoxy-11β-[4-N,N-dimethylamino-phenyl]-19-norpregna-4,9-diene-3,20-dione (ulipristal acetate). | ||
| 地址 | Paris FR | ||